このページの翻訳は実験的なもので、現在開発中です。お待ちしております！
Syngene International マネジメント
マネジメント 基準チェック /34
Syngene International'sの CEO はJonathan Huntで、 Jan2016年に任命され、 の在任期間は 8.42年です。 の年間総報酬は₹ 84.75Mで、 100%給与と0%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の0.087%を直接所有しており、その価値は₹ 241.58M 。経営陣と取締役会の平均在任期間はそれぞれ7.4年と6.9年です。
主要情報
Jonathan Hunt
最高経営責任者
₹84.8m
報酬総額
| CEO給与比率 | 100.0% |
| CEO在任期間 | 8.4yrs |
| CEOの所有権 | 0.06% |
| 経営陣の平均在職期間 | 7.4yrs |
| 取締役会の平均在任期間 | 6.9yrs |
経営陣の近況
Recent updates
These 4 Measures Indicate That Syngene International (NSE:SYNGENE) Is Using Debt Safely
Mar 28
Do Syngene International's (NSE:SYNGENE) Earnings Warrant Your Attention?
Feb 14Earnings Not Telling The Story For Syngene International Limited (NSE:SYNGENE)
Jan 19Is Syngene International (NSE:SYNGENE) A Risky Investment?
Nov 19Is Now The Time To Put Syngene International (NSE:SYNGENE) On Your Watchlist?
Nov 01Syngene International (NSE:SYNGENE) Seems To Use Debt Rather Sparingly
Aug 07These 4 Measures Indicate That Syngene International (NSE:SYNGENE) Is Using Debt Safely
Apr 28Here's Why We Think Syngene International (NSE:SYNGENE) Is Well Worth Watching
Apr 06Does Syngene International (NSE:SYNGENE) Deserve A Spot On Your Watchlist?
Jan 04Syngene International (NSE:SYNGENE) Has A Pretty Healthy Balance Sheet
Dec 08Is Syngene International (NSE:SYNGENE) Using Too Much Debt?
Aug 28Syngene International Limited (NSE:SYNGENE) Shares Could Be 22% Above Their Intrinsic Value Estimate
Aug 10These 4 Measures Indicate That Syngene International (NSE:SYNGENE) Is Using Debt Reasonably Well
May 10Does Syngene International (NSE:SYNGENE) Have A Healthy Balance Sheet?
Feb 02Does Syngene International (NSE:SYNGENE) Deserve A Spot On Your Watchlist?
Nov 26Here's Why Syngene International (NSE:SYNGENE) Can Manage Its Debt Responsibly
Sep 21Here's Why I Think Syngene International (NSE:SYNGENE) Is An Interesting Stock
Aug 06The CEO Of Syngene International Limited (NSE:SYNGENE) Might See A Pay Rise On The Horizon
Jul 14Is Syngene International (NSE:SYNGENE) A Risky Investment?
Jun 09CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | ₹5b |
| Dec 31 2023 | n/a | n/a | ₹5b |
| Sep 30 2023 | n/a | n/a | ₹5b |
| Jun 30 2023 | n/a | n/a | ₹5b |
| Mar 31 2023 | ₹85m | ₹85m | ₹5b |
| Dec 31 2022 | n/a | n/a | ₹4b |
| Sep 30 2022 | n/a | n/a | ₹4b |
| Jun 30 2022 | n/a | n/a | ₹4b |
| Mar 31 2022 | ₹76m | ₹76m | ₹4b |
| Dec 31 2021 | n/a | n/a | ₹4b |
| Sep 30 2021 | n/a | n/a | ₹4b |
| Jun 30 2021 | n/a | n/a | ₹4b |
| Mar 31 2021 | ₹65m | ₹65m | ₹4b |
| Dec 31 2020 | n/a | n/a | ₹4b |
| Sep 30 2020 | n/a | n/a | ₹4b |
| Jun 30 2020 | n/a | n/a | ₹4b |
| Mar 31 2020 | ₹66m | ₹66m | ₹4b |
| Dec 31 2019 | n/a | n/a | ₹4b |
| Sep 30 2019 | n/a | n/a | ₹4b |
| Jun 30 2019 | n/a | n/a | ₹3b |
| Mar 31 2019 | ₹90m | ₹47m | ₹3b |
| Dec 31 2018 | n/a | n/a | ₹3b |
| Sep 30 2018 | n/a | n/a | ₹3b |
| Jun 30 2018 | n/a | n/a | ₹3b |
| Mar 31 2018 | ₹94m | ₹47m | ₹3b |
報酬と市場: Jonathanの 総報酬 ($USD 1.01M ) は、 Indian市場 ($USD 519.16K ) の同規模の企業の平均を上回っています。
報酬と収益: Jonathanの報酬は、過去 1 年間の会社の業績と一致しています。
CEO（最高経営責任者
Jonathan Hunt (55 yo)
8.4yrs
在職期間
₹84,750,000
報酬
Mr. Jonathan Brittan Hunt serves as the Managing Director of Syngene International Limited since April 1, 2020. He has been the Chief Executive Officer of Syngene International Ltd. since January 2016 and...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| MD, CEO & Executive Director | 8.4yrs | ₹84.75m | 0.062% ₹ 176.7m | |
| CFO & Executive Director | 4.5yrs | ₹34.14m | 0.017% ₹ 48.5m | |
| Head of Investor Relations | no data | データなし | 0.0013% ₹ 3.7m | |
| Company Secretary & Compliance Officer | 4.9yrs | ₹4.72m | 0.0031% ₹ 8.9m | |
| Head of Corporate Communications | no data | データなし | データなし | |
| Chief Human Resources Officer | 1.5yrs | データなし | データなし | |
| Head of Pharmaceutical & Biopharmaceutical Development | no data | ₹10.80m | データなし | |
| Head of Formulations Development | no data | ₹5.50m | 0.029% ₹ 82.9m | |
| Head of IT | 8.3yrs | データなし | 0.00038% ₹ 1.1m | |
| Head of Discovery Biology | 8.4yrs | データなし | 0.0060% ₹ 17.1m | |
| Head of Clinical Development & Stability Studies | 8.4yrs | データなし | 0.0041% ₹ 11.6m | |
| Head of EHSS | 6.4yrs | データなし | 0.0063% ₹ 18.0m |
7.4yrs
平均在職期間
経験豊富な経営陣: SYNGENEの経営陣は経験豊富で経験豊富です（平均在職期間は7.4年）。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| MD, CEO & Executive Director | 7.1yrs | ₹84.75m | 0.062% ₹ 176.7m | |
| CFO & Executive Director | less than a year | ₹34.14m | 0.017% ₹ 48.5m | |
| Non-Executive Director | 23.8yrs | ₹7.25m | 0.0022% ₹ 6.3m | |
| Non-Executive Chairperson | no data | ₹8.23m | 0.0055% ₹ 15.7m | |
| Lead Independent Director | 6.9yrs | ₹7.57m | データなし | |
| Independent Director | 7.3yrs | ₹6.93m | 0.013% ₹ 35.6m | |
| Additional Independent Director | less than a year | データなし | データなし | |
| Independent Non Executive Director | 3yrs | ₹5.61m | データなし | |
| Non-Executive Independent Director | 9.8yrs | ₹7.91m | 0.013% ₹ 35.6m | |
| Additional Independent Director | 4.8yrs | ₹7.57m | データなし |
6.9yrs
平均在職期間
63yo
平均年齢
経験豊富なボード: SYNGENEの 取締役会 は 経験豊富 であると考えられます ( 6.9年の平均在任期間)。